Unique ID issued by UMIN | UMIN000039476 |
---|---|
Receipt number | R000045007 |
Scientific Title | Bavencio Intravenous200 mg Special Drug Use - results Survey (Curatively unresectable or metastatic renal cell carcinoma) |
Date of disclosure of the study information | 2020/02/13 |
Last modified on | 2024/02/19 10:08:15 |
Bavencio Intravenous200 mg Special Drug Use - results Survey (Curatively unresectable or metastatic renal cell carcinoma)
Bavencio Special Drug Use-results Survey (Renal cell carcinoma)
Bavencio Intravenous200 mg Special Drug Use - results Survey (Curatively unresectable or metastatic renal cell carcinoma)
Bavencio Special Drug Use-results Survey (Renal cell carcinoma)
Japan |
Curatively unresectable or metastatic renal cell carcinoma
Urology |
Malignancy
NO
Survey safety and effectiveness of Bavencio Intravenous 200 mg in clinical practice
Safety,Efficacy
Incidence of all Adverse drug reactions / all Adverse Events related to the Safety Specification
Effectiveness in terms of Best Overall Response and Overall Survival
Observational
Not applicable |
Not applicable |
Male and Female
All patients who received at least one dose of Bavencio for Curatively unresectable or metastatic renal cell carcinoma during the enrollment period.
None
250
1st name | Hidehiko |
Middle name | |
Last name | Momo |
Merck Biopharma Co., Ltd.
PMS Planning & Strategy, Medical Department
153-8926
Arco Tower 4F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo, Japan
03-6756-0791
hidehiko.momo@merckgroup.com
1st name | Taito |
Middle name | |
Last name | Ito |
Merck Biopharma Co., Ltd.
PMS Planning & Strategy, Medical Department
153-8926
Arco Tower 4F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo, Japan
03-6756-0805
taito.ito@merckgroup.com
Merck Biopharma Co., Ltd.
Merck Biopharma Co., Ltd.
Profit organization
Merck Biopharma Co., Ltd.
Arco Tower 4F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo, Japan
03-6756-0805
taito.ito@merckgroup.com
NO
2020 | Year | 02 | Month | 13 | Day |
Unpublished
No longer recruiting
2019 | Year | 12 | Month | 20 | Day |
2019 | Year | 12 | Month | 20 | Day |
2019 | Year | 12 | Month | 20 | Day |
2022 | Year | 10 | Month | 31 | Day |
Special Drug Use-Results Survey according to the GPSP ordinance
2020 | Year | 02 | Month | 13 | Day |
2024 | Year | 02 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045007
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |